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Background. Approximately 8% of autosomal-dominant
polycystic kidney disease (ADPKD) patients have intracranial
aneurysms. The risk of growth and rupture of those discovered
by presymptomatic screening is key to the feasibility and suc-
cess of a screening program. This study was initiated to ascertain
this risk.
Methods. ADPKD patients were offered screening with mag-
netic resonance (MR) imaging that included three-dimensional
time-of-flight MR angiographic and three-dimensional phase-
contrast sequences. Patients with aneurysms were recom-
mended periodic surveillance, initially at 6 months and yearly,
and less frequently after demonstration of their stability.
Results. Twenty-two saccular and one fusiform aneurysms
were detected at the initial screening in 21 patients from 19
families (seven men and 14 women, 47.9 ± 10.6 years old). All
the saccular aneurysms were small (mean diameter 3.5 mm,
range 2.0 to 6.5 mm) and the majority (77%) in the anterior
circulation. Two patients died from unrelated causes without
further follow-up. One patient was lost to follow-up. A new
2 mm middle cerebral artery aneurysm developed in one pa-
tient. One aneurysm increased from a size of 4 mm to 5 mm
after a follow-up of 105 months. No aneurysmal development
or growth occurred in the remaining 16 patients. No aneurys-
mal rupture occurred during a mean imaging follow-up of 81
months and a mean clinical follow-up of 92 months. During
the period of the study, two additional ADPKD patients, with
three intracranial aneurysms detected elsewhere by presymp-
tomatic MR angiographic screening, were referred for surgical
treatment. The larger size of these aneurysms (10, 8, and 8 mm)
probably reflects referral bias.
Conclusion. Most intracranial aneurysms detected by
presymptomatic screening in ADPKD patients are small and
in the anterior circulation. The follow-up results do not suggest
an increased risk for growth and rupture, compared to those of
intracranial aneurysms in the general population. These data do
not support widespread screening for intracranial aneurysms in
the ADPKD population.
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Autosomal-dominant polycystic kidney disease
(ADPKD) patients with either PKD1 or PKD2 muta-
tions are at risk for intracranial aneurysms [1]. The high
mortality and morbidity associated with their rupture
have led physicians to consider the value of screening
ADPKD patients for unruptured intracranial aneurysms
(UIAs) [2]. The efficacy of a screening program de-
pends heavily upon the sensitivity and specificity of the
screening modality, the prevalence of disease, and the
potential benefit of a positive diagnosis. High-resolution
three-dimensional time-of-flight magnetic resonance
(MR) angiography is most commonly used to screen
for UIA [3]. It carries no risk of ionizing radiation, is
noninvasive, and unlike computed tomography (CT)
angiography does not use iodinated contrast, which may
be nephrotoxic. The prevalence of UIA in ADPKD
populations is approximately 8% (about five times higher
than in the general population) [4–6]. The majority of
UIAs discovered by presymptomatic screening are small
and presumed to have a low risk of rupture. While
there is a significant volume of literature on the risk of
rupture of asymptomatic UIA in the general population
[7, 8], the risk of rupture in ADPKD patients is not as
well defined. Preliminary data on ten ADPKD patients
with asymptomatic UIA who underwent serial MR
angiographies showed no increase in size or de novo
aneurysm formation after a mean imaging follow-up of
36 months (range 14 to 51 months) and clinical follow-up
of 42 months (range 14 to 54 months) [9]. The purpose of
this article is to update this 1996 report on a prospective
MR angiography study that now includes 18 ADPKD
patients with serial MR angiographies, a mean imaging
follow-up of 81 months (range 13 to 160 months) and a
mean clinical follow-up of 92 months (range 18 to 187
months).
METHODS
We reviewed the medical records of all the patients
with ADPKD and a diagnosis of UIA established by
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Table 1. Autosomal-dominant polycystic kidney disease (ADPKD) patients with asymptomatic intracranial aneurysms detected by
presymptomatic screening
Interval Clinical
Number Family from first follow-up
of MR history of to last MR from first MR
Patient Age and Aneurysm Size angiography intracranial angiography angiography
number gender location mm studies aneurysms months months Findings
1 45 F Basilar tip 2 9 Positive 160 187 No growth/de novo detection
2 72 F Left carotid siphon 2.5 7 Positive 132 134 No growth/de novo detection
3 49 F Right carotid siphon 6 5 Positive 125 139 No growth/de novo detection
4 27 M Right middle cerebral 3 6 Positive 129 129 No growth/new left middle
cerebral artery
5 45 F Right superior cerebellar 1.5 8 Positive 109 133 No growth/de novo detection
6 58 F Right carotid siphon 4 7 Positive 108 145 No growth/de novo detection
7 45 F Left superior cerebellar 4 5 Negative 105 105 Increased to 5 mm
8 45 M Right middle cerebral 3 3 Positive 99 99 No growth/de novo detection
9 41 M Anterior communicating 3 5 Positive 94 94 No growth/de novo detection
10 36 F Right periophthalmic 3.5 4 Positive 90 103 No growth/de novo detection
11 55 F Basilar tip 3 3 Positive 72 87 No growth/de novo detection
12 47 F Left carotid siphon 4 4 Negative 70 70 No growth/de novo detection
13 37 F Left carotid siphon 3 4 Negative 48 60 No growth/de novo detection
14 63 M Right middle cerebral 3 4 Positive 36 49 No growth/de novo detection
15 33 F Right middle cerebral 6.5 3 Negative 36 48 No growth/de novo detection
16 61 M Right anterior cerebral 3.5 3 Positive 19 36 No growth/de novo detection
17 42 M Left superior cerebellar 2.5 3 Negative 15 27 No growth/de novo detection
18 51 F Bilateral middle cerebral 2.5,2 2 Positive 13 18 No growth/de novo detection
19 47 F Right middle cerebral 5 1 Positive 0 65 Not restudied
20 52 M Left carotid siphon 6.5 1 Negative 0 8 Not restudied
21 55 F Left carotid siphon 4.5 1 Negative 0 0 Not restudied
presymptomatic screening at the Mayo Clinic between
1989 and 2002 to ascertain their risk for growth and
rupture. MR angiographic screening was offered to all
ADPKD patients seen between 1989 and 1992 [9]. Af-
ter 1992, screening was offered to patients with indica-
tions such as a family history of aneurysms or preparation
for major elective surgeries. The screening technique was
three-dimensional time-of-flight MR angiography. Treat-
ment decisions were independent from the study.
Patients were examined using a 1.5 T and 3.0 T Su-
perconducting Imaging Systems (Signa, GE Medical Sys-
tems, Milwaukee, WI, USA). Standard MR imaging
of the head was performed with sagittal T1-weighted
and transaxial T2-weighted sequences. In addition, high-
resolution 3 mm transaxial T1-weighted imaging through
the circle of Willis was obtained. The 1.5 T time-of-flight
technique includes a 38/3.4 (TR/TE), 1.4 mm section
thickness (zero filled for 0.7 mm overlap), 32 sections per
slab with 6 section overlap, 18 cm field of view, 25◦ flip
angle, 384 × 224 matrix with 512 zero filling in frequency
and phase encoding directions, and the use of magnetiza-
tion transfer. MR angiographic techniques have evolved
during the period of this study. Currently, 3.0 T time-of
flight MR angiograms offer the highest quality imaging
for detecting and characterizing UIA.
Maximum intensity projection postprocessing was per-
formed by isolating the right-carotid, left-carotid, and
posterior circulations. Care was taken to include the ante-
rior communicating artery in both carotid volumes. This
subvolume technique was necessary to display the arterial
vasculature optimally as well as to eliminate overlapping
vessels. Correlation between viewing the subvolumes in
a cine loop on an independent workstation and with the
source images facilitated identification and characteriza-
tion of the aneurysms. A saccular UIA was diagnosed
when a focal, asymmetric outpouching of an artery with
a discrete base was detected.
RESULTS
One fusiform and 22 saccular aneurysms were detected
at the time of the initial evaluation in 21 patients from 19
families (seven men and 14 women, 47.9 ± 10.6 years old).
All the saccular aneurysms were small with a mean diam-
eter of 3.5 mm at diagnosis (range 1.5 to 6.5 mm). Seven-
teen saccular aneurysms were in the anterior circulation
(seven middle cerebral artery, seven internal carotid
artery, one ophthalmic artery, one anterior communicat-
ing artery, and one anterior cerebral artery) and five in
the posterior circulation (three superior cerebellar artery
and two basilar artery). One patient had bilateral middle
cerebral artery aneurysms and another had an anterior
communicating artery aneurysm and a fusiform basilar
artery aneurysm. Fourteen of 21 patients (67%) had a
family history of intracranial aneurysms. Seven patients
had PKD1 mutations and one had a PKD2 mutation.
The genotype in the other 13 patients has not been de-
termined. Demographic and follow-up data of the 21 pa-
tients is summarized in Table 1.
Gibbs et al: Follow-up of intracranial aneurysms in ADPKD 1623
Because of the small size of the aneurysms and based
on available natural history data, no surgical or en-
dovascular intervention was recommended. The patients
were instructed to eliminate tobacco, aggressively treat
hypertension, and lower serum cholesterol. They were
also advised to have periodic surveillance, initially at
6 months and yearly, and less frequently thereafter, after
demonstration of stability of the aneurysms. Two of the
patients died from unrelated causes without further
follow-up (one after discontinuation of dialysis and the
other in a motor vehicle accident). One patient was lost
to follow-up. The remaining 18 patients had at least two
MR angiographic studies, with a mean of 4.7 MR an-
giographies completed per patient (range 2 to 9) and cu-
mulative imaging and clinical follow-ups of 1460 and 1663
months, respectively. The mean interval between the ini-
tial and the last MR angiogram was 81 months (range
13 to 160 months). A new, 2 mm, left middle cerebral
artery aneurysm that was a mirror of a right middle cere-
bral artery aneurysm developed in one patient. Follow-
ing its detection, this aneurysm has not changed in size
or configuration over a period of 5 years. One aneurysm
increased from a size of 4 mm to 5 mm after a follow-up
of 105 months. No aneurysmal development or growth
occurred in the remaining 16 patients. The mean dura-
tion of the clinical follow-up was 92 (range 18 to 187)
months. Nine never used tobacco, seven were previous
smokers or quit following the diagnosis of the aneurysm,
and two continued to be active smokers. Two patients
were normotensive. Hypertension was deemed to be ad-
equately controlled in the remaining patients, requiring
an average of 1.9 antihypertensive drugs per patient. Six
patients were treated with statins. The remaining were
managed with diet alone [low-density lipoprotein (LDL)
cholesterol 119 ± 41 mg/dL when last measured]. None
of the patients experienced an aneurysmal rupture.
During the period of the study, two ADPKD patients
with UIAs detected by presymptomatic screening else-
where were referred to our center for treatment. One pa-
tient had an 8 mm left middle cerebral artery aneurysm
and the other had two aneurysms, a 10 mm right mid-
dle cerebral artery aneurysm and an 8 mm left posterior
communicating artery aneurysm. The larger size of the
aneurysms in these referred patients, compared to those
diagnosed in our center, likely reflects referral bias. Both
patients underwent surgical clipping of the aneurysm.
An observation from this study is the noticeable im-
provement in image quality of MR angiography. Figure 1
shows three serial MR angiograms of five different pa-
tients performed over a several-year interval. In each
example, the vessel clarity is improved in the studies
performed on the later dates. Figure 2 shows a 2 mm
superior cerebellar artery aneurysm that is more clearly
seen on more recent studies than those performed in the
early 1990s. The most recent image was performed using
a 3.0 T strength magnet. The technical advances in MR
imaging have allowed MR angiography to better define
aneurysm morphology. Detection of smaller aneurysms
with greater confidence is possible with state of the art
equipment including 3.0 T units. Despite improved im-
age quality, aneurysm detection was not changed in any
of these cases. However, a lesion that was initially thought
to be a 2 mm aneurysm at the M1 segment of the middle
cerebral artery, was shown to be an infundibulum on a
more recent exam utilizing advanced MR angiographic
techniques (Fig. 3). This patient has been excluded from
the series. In another patient, a new left middle cere-
bral artery aneurysm developed, and the apparent size
of a right middle cerebral artery aneurysm appeared
to increase from 1.5 mm to 3 mm. Comparison of the
studies revealed that this was due to technical improve-
ments in the MR angiographic technique rather than to
a true change in aneurysm size, as the apparent size of
all visualized vessels also increased due to the improved
sequences, including shorter echo times, echo speed gra-
dients, and the use of flow compensation (Fig. 4).
DISCUSSION
Most UIAs discovered by screening asymptomatic
ADPKD patients are small [4–6]. A significant volume of
literature indicates that the risk of rupture for these small
asymptomatic UIA in the general population is very small
[7, 8]. However, the data are complex and the risk is de-
pendent not only on aneurysm size, but also on aneurysm
site and whether the patient has a prior history of sub-
arachnoid hemorrhage from another aneurysms. There
is less certainty on whether the behavior of aneurysms in
patient populations predisposed to UIA is similar to that
of sporadic aneurysms in the general population.
In 1998, the International Study of Unruptured In-
tracranial Aneurysms (ISUIA) showed that the rupture
of asymptomatic aneurysms measuring less than 10 mm
in patients without a history of subarachnoid hemor-
rhage is 0.05% annually [7]. This rate increases to 0.5%
in patients with a history of subarachnoid hemorrhage
from another ruptured aneurysm. The rate of aneurysms
10 mm or more in diameter was less than 1% in both
groups, but a 6% rupture rate in the first year was 6%
for giant aneurysms measuring 25 mm or more in diame-
ter. These rates of rupture were lower than expected. The
publication of the ISUIA Study gave rise to a number of
criticisms and spirited debate. In particular, the retrospec-
tive nature of the study, the inclusion of UIAs with low
risk for subarachnoid hemorrhage (intracavernous and
infraclinoid ophthalmic aneurysms), and the short dura-
tion of follow-up were perceived as limiting the validity
of the study. More recently the results of the prospec-
tive arm of ISUIA have been published and to a signifi-
cant extent have confirmed the results of the retrospective
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Fig. 1. Serial MR angiogram images in five
different patients. No change was seen in
aneurysm size or morphology. Image quality
improved noticeably from 1991 to 2001.
arm of the study [8]. Of 4060 patients in the study, 1692
did not have aneurysmal repair. The 5-year cumulative
rupture rates for patients without a previous history of
subarachnoid hemorrhage with aneurysms located in the
internal carotid artery, anterior communicating or ante-
rior cerebral artery, or middle cerebral artery were 0%,
2.6%, 14.5%, and 40% for aneurysms less than 7 mm,
7 to 12 mm, 13 to 24 mm, and 25 mm or greater, re-
spectively, compared with rates of 2.5%, 14.5%, 18.4%,
and 50%, respectively, for the same size categories in-
volving the posterior circulation and posterior communi-
cating artery. Among unruptured noncavernous segment
aneurysms less than 7 mm in diameter, the rupture risks
were higher among those who had a previous subarach-
noid hemorrhage from another intracranial aneurysm.
The risks associated with surgical or endovascular re-
pair of comparable lesions were also reported. The 1-year
mortality and combined morbidity (Rankin score 3 to 5 or
impaired cognitive status) and mortality rates for surgical
or endovascular repair of aneurysms in patients without
a prior history of subarachnoid hemorrhage from a dif-
ferent aneurysm were 2.7% and 12.6% for open surgery
and 3.4% and 9.8% for endovascular repair.
Preliminary data on 10 patients with small (<6.5 mm)
UIAs detected by presymptomatic screening showed
no change in aneurysmal size or development of new
aneurysms after a mean clinical follow-up of 33.3 months
and imaging follow-up of 30.6 months [9]. Another
study of nine ADPKD patients with UIAs detected
by presymptomatic MR angiography or conventional
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Fig. 2. Serial time-of-flight MR angiography
of a 3 mm superior cerebellar aneurysm be-
tween 1991 and 2000 shows noticeable im-
provement in image quality during the course
of the study. The 2000 exam was performed
using a magnetic field strength of 3 T, where
the other studies were performed at 1.5 T.
angiography screening and restudied between 1.6 and
12.7 years after the initial diagnosis (mean follow-up
7.7 years) demonstrated the development of a new 2.5
mm aneurysm in the anterior circulation and an increase
in size of a middle cerebral artery aneurysm [10]. The
observations in the current study on 17 patients with an
imaging follow-up of 81 months and clinical follow-up of
92 months confirm that the risk of growth and develop-
ment of new aneurysms in patients with small (<7 mm
in diameter) UIAs detected by presymptomatic screen-
ing is low and suggest that their risk of rupture may
not be higher than that reported among non-ADPKD
aneurysms. This is consistent with available data on the
prevalence of UIA and the incidence of aneursymal rup-
ture in ADPKD. The prevalence of UIA in this pop-
ulation is approximately 8%, about five times higher
than in the general population [4–6]. The incidence of
aneurysmal rupture in ADPKD patients in Rochester,
Minnesota, is approximately 1/2000 person-years [11] or
five times higher than that observed in the in the gen-
eral population, 1:10,000 [12]. Thus, it appears that both,
the prevalence of unruptured intracranial aneurysms and
the incidence of aneurysmal rupture are similarly higher
in the ADPKD than in the general population. Since 14
of the 21 (67%) patients in the study had a family his-
tory of intracranial aneurysm, the data do not support a
substantial increase in risk for rupture in this particular
population.
Since most aneurysms detected by presymptomatic
screening are small and have a low risk of rapid growth or
rupture, we do not recommend presymptomatic screen-
ing for UIAs for patients with a negative family history
of UIA. Screening MR angiography is offered to those
patients with a family history of documented aneurys-
mal rupture, because of the higher prevalence of UIAs in
this population and uncertainties remaining on the nat-
ural history of these aneurysms. If the screening MR an-
giography is negative, rescreening of patients with good
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Fig. 3. Maximum intensity projection image
from MR angiogram of November 15, 1996,
shows a prominent infundibulum of the M1
segment of the middle cerebral. This was pre-
viously thought to be a 2 mm aneurysm on
MR angiogram of January 23, 1996.
Fig. 4. Development of a new left middle cerebral artery aneurysm. (A) Only a small right middle cerebral artery aneurysm was detected in the
initial study. (B) Three years later, a small mirror aneurysm had developed in the left middle cerebral artery; technical factors accounted for the
slight change in appearance of the right middle cerebral artery aneurysm. (C and D) Both aneurysms remain stable 2 and 5 years later.
life expectancy at 5-year intervals seems reasonable. If
an aneurysm is detected, recommendations are depen-
dent on patient age, overall medical status, and numerous
aneurysm factors including size, and aneurysm site.
Decisions regarding the management of UIA are com-
plex and multiple factors need to be considered, includ-
ing size, site, prior history of subarachnoid hemorrhage
from another aneurysm, aneurysm morphology, patient
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age and general health, and whether the aneurysms is
coilable or clippable. The results of this study support
the conservative management of ADPKD patients with
small (particularly those measuring less than 7 mm), an-
terior circulation asymptomatic intracranial aneurysms,
detected by presymptomatic screening. After considering
all aneurysm and patient characteristics, should interven-
tion be indicated then endovascular or surgical manage-
ment should be based on a multidisciplinary review. For
untreated small aneurysms, annual or semiannual repeat
imaging studies are appropriate initially, but reevalua-
tion at less frequent intervals may be sufficient once the
stability of the size of the UIA has been documented. Pa-
tients should be advised to eliminate tobacco use, aggres-
sively treat hypertension, and to lower blood cholesterol
to minimize their independent risk factors of aneurysm
formation [13].
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